Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/15120
SCHISTOSOME-INDUCED CHOLANGIOCYTE PROLIFERATION AND OSTEOPONTIN SECRETION CORRELATE WITH FIBROSIS AND PORTAL HYPERTENSION IN HUMAN AND MURINE SCHISTOSOMIASIS MANSONI
Ductular proliferation
Osteopontin
Portal hypertension
Schistosomiasis mansoni
Symmers’ fibrosis
Author
Pereira, Thiago de Almeida
Syn, Wing-Kin
Machado, Mariana V
Vidigal, Paula Vieira Teixeira
Resende, Vivian
Voieta, Izabela
Xie, Guanhua
Otoni, Alba
Souza, Márcia Maria de
Santos, Elisângela Trindade
Chan, Isaac S
Trindade, Guilherme Vaz de Melo
Choi, Steve S
Witek, Rafal P
Pereira, Fausto Edmundo Lima
Secor, William E
Andrade, Zilton de Araújo
Lambertucci, José Roberto
Diehl, Anna Mae
Syn, Wing-Kin
Machado, Mariana V
Vidigal, Paula Vieira Teixeira
Resende, Vivian
Voieta, Izabela
Xie, Guanhua
Otoni, Alba
Souza, Márcia Maria de
Santos, Elisângela Trindade
Chan, Isaac S
Trindade, Guilherme Vaz de Melo
Choi, Steve S
Witek, Rafal P
Pereira, Fausto Edmundo Lima
Secor, William E
Andrade, Zilton de Araújo
Lambertucci, José Roberto
Diehl, Anna Mae
Affilliation
Duke University Medical Center. Department of Medicine. Division of Gastroenterology. Durham, U.S.A. / Fundação Gonçalo Moniz. Centro de Pesquisas Gonçalo Moniz. Laboratório de Patologia Experimental. Salvador, BA, Brasil
Foundation for Liver Research. Institute of Hepatology. Liver Regeneration and Repair Research Group. London, U.K. / Loyola University. Department of Surgery. Chicago, Maywood, U.S.A.
Duke University Medical Center. Department of Medicine. Division of Gastroenterology. Durham, U.S.A.
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil
Duke University Medical Center. Department of Medicine. Division of Gastroenterology. Durham, U.S.A.
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil
Fundação Gonçalo Moniz. Centro de Pesquisas Gonçalo Moniz. Laboratório de Patologia Experimental. Salvador, BA, Brasil
Fundação Gonçalo Moniz. Centro de Pesquisas Gonçalo Moniz. Laboratório de Patologia Experimental. Salvador, BA, Brasil
Duke University Medical Center. Department of Medicine. Division of Gastroenterology. Durham, U.S.A.
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil
Duke University Medical Center. Department of Medicine. Division of Gastroenterology. Durham, U.S.A.
Life Technologies. Frederick, MD, U.S.A.
Universidade Federal do Espírito Santo. Núcleo de Doenças Infecciosas. Vitória, ES, Brasil
Centers for Disease Control and Prevention. Atlanta, GA, U.S.A.
Fundação Gonçalo Moniz. Centro de Pesquisas Gonçalo Moniz. Laboratório de Patologia Experimental. Salvador, BA
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil
Duke University Medical Center. Department of Medicine. Division of Gastroenterology. Durham, U.S.A.
Foundation for Liver Research. Institute of Hepatology. Liver Regeneration and Repair Research Group. London, U.K. / Loyola University. Department of Surgery. Chicago, Maywood, U.S.A.
Duke University Medical Center. Department of Medicine. Division of Gastroenterology. Durham, U.S.A.
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil
Duke University Medical Center. Department of Medicine. Division of Gastroenterology. Durham, U.S.A.
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil
Fundação Gonçalo Moniz. Centro de Pesquisas Gonçalo Moniz. Laboratório de Patologia Experimental. Salvador, BA, Brasil
Fundação Gonçalo Moniz. Centro de Pesquisas Gonçalo Moniz. Laboratório de Patologia Experimental. Salvador, BA, Brasil
Duke University Medical Center. Department of Medicine. Division of Gastroenterology. Durham, U.S.A.
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil
Duke University Medical Center. Department of Medicine. Division of Gastroenterology. Durham, U.S.A.
Life Technologies. Frederick, MD, U.S.A.
Universidade Federal do Espírito Santo. Núcleo de Doenças Infecciosas. Vitória, ES, Brasil
Centers for Disease Control and Prevention. Atlanta, GA, U.S.A.
Fundação Gonçalo Moniz. Centro de Pesquisas Gonçalo Moniz. Laboratório de Patologia Experimental. Salvador, BA
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil
Duke University Medical Center. Department of Medicine. Division of Gastroenterology. Durham, U.S.A.
Abstract
Schistosomiasis is a major cause of portal hypertension worldwide. It associates with portal fibrosis that develops during chronic infection. The mechanisms by which the pathogen evokes these host responses remain unclear. We evaluated the hypothesis that schistosome eggs release factors that directly stimulate liver cells to produce osteopontin (OPN), a pro-fibrogenic protein that stimulates hepatic stellate cells to become myofibroblasts. We also investigated the utility of OPN as a biomarker of fibrosis and/or severity of portal hypertension. Cultured cholangiocytes, Kupffer cells and hepatic stellate cells were treated with soluble egg antigen (SEA); OPN production was quantified by quantitative reverse transcriptase polymerase chain reaction (qRTPCR) and ELISA; cell proliferation was assessed by BrdU (5-bromo-2'-deoxyuridine). Mice were infected with Schistosoma mansoni for 6 or 16 weeks to cause early or advanced fibrosis. Liver OPN was evaluated by qRTPCR and immunohistochemistry (IHC) and correlated with liver fibrosis and serum OPN. Livers from patients with schistosomiasis mansoni (early fibrosis n=15; advanced fibrosis n=72) or healthy adults (n=22) were immunostained for OPN and fibrosis markers. Results were correlated with plasma OPN levels and splenic vein pressures. SEA-induced cholangiocyte proliferation and OPN secretion (P<0.001 compared with controls). Cholangiocytes were OPN (+) in Schistosoma-infected mice and humans. Liver and serum OPN levels correlated with fibrosis stage (mice: r=0.861; human r=0.672, P=0.0001) and myofibroblast accumulation (mice: r=0.800; human: r=0.761, P=0.0001). Numbers of OPN (+) bile ductules strongly correlated with splenic vein pressure (r=0.778; P=0.001). S. mansoni egg antigens stimulate cholangiocyte proliferation and OPN secretion. OPN levels in liver and blood correlate with fibrosis stage and portal hypertension severity.
Keywords
CholangiocyteDuctular proliferation
Osteopontin
Portal hypertension
Schistosomiasis mansoni
Symmers’ fibrosis
Share